Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for High Cholesterol in High-Risk CHD Patients
NCT00644709Phase 4Completed
- Sponsor
- Viatris
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in dyslipidemia, sponsored by Viatris. Primary endpoint: Achievement of low-density lipoprotein cholesterol (LDL-C) target of <115 mg/dL at Week 52. Started Sep 2003; status: completed.
02
Drugs
atorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00644709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644709.